Pricing Log in Create free account
Friday 6 November 2026 Export OPCH’s income statement to Excel — free account

Option Care Health, Inc.

OPCH Healthcare Medical Care Facilities

Option Care Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.6 billion, up 13.0% from fiscal 2024.

Revenue
+4.08%
EPS
+19.8%
Free cash flow
−17.0%
Total debt
−0.93%

Quarter to September 2026, against a year earlier

31.52 0.13 −0.41%
Market cap
$4.7B
P/E
22.6×
Fwd P/E
21.2×
Dividend yield
—
F-score
5/9
Altman Z
3.92
Beneish M
−2.38
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Bought, $m 1.88
Sold, $m 1.17
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — 4 — — — — — —
Sell — — 2 — — — — — — — — —
Insider Ownership 1.75%

Capital & Financial Ratios $m

Size
Market Cap 4,720.00
Revenue ttm 5,752.03
Net income ttm 215.19
Free cash flow ttm 281.65
Net debt Q 851.96
Valuation
P/E 22.62
Forward P/E 21.20
Price / sales 0.82
Forward P/S Powerpack
Price / FCF 16.76
Price / book 3.75
Financial health
Current ratio Q 1.54 (at or above 1.5: strong)
Debt / equity Q 0.87
Interest coverage Q 6.93
Growth
Revenue growth Q +4.08% (above 0%: growing)
Operating income growth Q +5.57% (above 0%: growing)
EPS, this year +9.27%
EPS, next year A +10.89%
Revenue, next year A +1.90%
EPS, past 5 yrs —
EPS, next 5 yrs A +10.80%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.0×, against a ten-year median of 1.2×; over the ten years it ranged from 0.4× in 2018 to 1.9× in 2022.
P/E against its own 10 years 31.68%
10-year low 10-year high
P/S against its own 10 years 40.78%
10-year low 10-year high
P/B against its own 10 years 55.90%
10-year low 10-year high
EV/Sales against its own 10 years 35.31%
10-year low 10-year high
EV/FCF against its own 10 years 20.96%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 344 413 233 299
Receivables 378 410 474 506
Inventory 274 388 471 408
Other — — — —
1,094 1,323 1,265 1,312
2023 2024 2025 Q'26
Payables 427 611 640 671
ST’ Debt 6 7 7 —
Other — — — 180
618 780 829 851

Compound Annual Growth %

10y 5y 3y
Sales 19.12% 13.25% 12.72%
Cash Flow 0.00% 15.20% (1.15%)
Earnings 0.00% 0.00% 11.30%
Book Value 0.00% 5.48% (1.46%)

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 0.48 Actual 0.49

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 0.46 0.46 Met by 0.00
Q1 FY26 0.37 0.40 Beat by 0.03
Q2 FY26 0.42 0.45 Beat by 0.03
Q3 FY26 0.48 0.49 Beat by 0.01
Q4 FY26 0.54 — Reports 23 February 2027

EPS $

Mar Jun Sep Dec Year
’26 0.29 0.35 0.38 — —
’25 0.28 0.31 0.32 0.37 1.27
’24 0.26 0.30 0.31 0.35 1.23
’23 0.21 0.63 0.31 0.32 1.48
’22 0.17 0.19 0.21 0.26 0.83
’21 (0.02) 0.18 0.20 0.41 0.77
’20 (0.11) (0.04) 0.01 0.10 (0.04)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 1,351 1,442 1,494 — —
’25 1,333 1,416 1,435 1,465 5,650
’24 1,146 1,227 1,279 1,346 4,998
’23 1,016 1,069 1,093 1,124 4,302
’22 916 981 1,021 1,027 3,945
’21 759 860 892 927 3,439
’20 705 741 782 805 3,033
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (12) 184 115 — —
’25 (7) 90 139 36 258
’24 (69) 196 160 36 323
’23 90 170 61 51 371
’22 33 104 87 43 268
’21 18 74 51 65 209
’20 18 35 48 26 127
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (21) 173 108 — —
’25 (17) 81 130 22 217
’24 (75) 186 151 26 288
’23 84 162 53 35 333
’22 27 100 80 40 247
’21 15 70 46 51 183
’20 13 31 45 12 101
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.9
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 936 1,828 1,940 2,310 3,033 3,439 3,945 4,302 4,998 5,650 5,752 +22.1% 5,757 6,126 6,621 +5.4%
Gross margin, % 28.01 24.40 21.77 22.20 22.50 22.67 21.98 22.81 20.27 19.26 19.07 (8.8) pt
EBT (34) (15) (9) (78) (5) 116 206 359 284 283 295 n/m
EBT margin, % (3.65) (0.80) (0.45) (3.38) (0.17) 3.39 5.22 8.34 5.67 5.01 5.14 +8.7 pt
Net income (43) 4 (6) (76) (8) 140 151 267 212 208 215 n/m
Per share, $
Per share, $ Revenue 39.92 12.82 13.60 14.78 16.76 19.12 21.78 24.04 29.13 34.85 38.40 (1.5%)
Earnings (2.16) 0.03 (0.04) (0.49) (0.04) 0.78 0.83 1.49 1.23 1.28 1.39 n/m
Cash flow (1.82) 0.27 0.17 0.25 0.70 1.16 1.48 2.07 1.88 1.59 2.15 n/m
Capex (0.24) (0.17) (0.18) (0.18) (0.15) (0.14) (0.11) (0.21) (0.21) (0.25) (0.27) +0.5%
Free cash flow (2.06) 0.09 (0.01) 0.07 0.56 1.02 1.36 1.86 1.68 1.34 1.88 n/m
Book value 1.64 (0.59) 4.23 5.80 5.61 6.54 7.65 7.94 8.18 8.18 8.84 +19.6%
Shares, m 23 143 143 156 181 180 181 179 172 162 155 +24.0%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 36.27 35.54 23.03 18.56 24.89 22.62 13.8
P/S 0.14 0.95 1.05 1.01 0.93 1.49 1.35 1.43 0.80 0.91 0.82 1.0
P/B 0.00 0.00 3.38 2.57 2.79 4.35 3.85 4.32 2.83 3.89 3.75 2.8
EV/Sales 0.61 1.19 1.31 1.54 1.27 1.76 1.55 1.59 0.94 1.08 0.97 1.3
EV/FCF (11.87) 162.83 (1,374.19) (913.83) 38.36 33.13 24.76 20.59 16.26 28.06 19.81 (197.6)
Cash, $m
Cash, $m Operating cash flow (43) 38 24 39 127 209 268 371 323 258 322 n/m
Capex (6) (24) (26) (28) (27) (26) (21) (38) (36) (41) (40) +24.6%
Free cash flow (48) 13 (2) 11 101 183 247 333 288 217 282 n/m
Balance, $m
Balance, $m Working capital 43 81 227 229 223 251 429 476 542 436 462 +29.3%
Net debt 442 436 503 1,219 1,025 946 770 719 699 928 852 +8.6%
Shareholders’ equity 38 (85) 603 907 1,016 1,176 1,386 1,422 1,404 1,326 1,324 +48.2%
Returns, %
Returns, % ROA (9.13) 0.64 (0.60) (3.78) (0.31) 5.14 5.10 8.44 6.38 6.04 6.19 +15.2 pt
ROIC (1.43) 4.85 2.16 (0.01) 3.39 5.62 6.96 9.19 9.57 9.37 9.72 +10.8 pt
ROE 90.57 (6.55) (2.36) (10.06) (0.84) 12.77 11.75 19.03 14.99 15.20 16.04 (75.4) pt
People
People Employees 2,540 2,154 2,043 5,903 5,852 7,238 8,058 7,802 8,088 8,266 — +14.0%
Revenue/emp, $m 0.37 0.85 0.95 0.39 0.52 0.48 0.49 0.55 0.62 0.68 — +7.1%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Option Care Health, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
PACS PACS Group, Inc. $8.0B 28.6× 21.8× +11.45% (above 0%: growing) +16.36% (above 0%: growing) −4.31% (below 0%: shrinking) 17.23% 6.65% Compare
CHE Chemed Corporation $7.0B 25.5× 24.0× +10.57% (above 0%: growing) +23.09% (above 0%: growing) −45.25% (below 0%: shrinking) 33.72% 13.96% Compare
CON Concentra Group Holdings Parent, Inc. $5.4B 24.9× 25.2× +8.61% (above 0%: growing) +36.84% (above 0%: growing) −19.76% (below 0%: shrinking) 31.42% 18.52% Compare
LFST LifeStance Health Group, Inc. $5.1B 70.7× 81.1× +25.30% (above 0%: growing) +2,042.86% (above 0%: growing) +31.57% (above 0%: growing) 0.00% 7.26% Compare
OPCH Option Care Health, Inc. $4.7B 22.6× 21.2× +4.08% (above 0%: growing) +19.81% (above 0%: growing) −17.04% (below 0%: shrinking) 19.08% 5.97%
NHC National HealthCare Corporation $3.3B 28.2× 8.4× +6.61% (above 0%: growing) −65.61% (below 0%: shrinking) +75.52% (above 0%: growing) 100.00% 0.00% Compare
ACHC Acadia Healthcare Company, Inc. $3.2B — (loss-making) 34.4× +5.14% (above 0%: growing) −5.00% (below 0%: shrinking) +196.54% (above 0%: growing) 100.00% 0.00% Compare
SGRY Surgery Partners, Inc. $3.0B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
AVAH Aveanna Healthcare Holdings Inc. $3.0B 10.5× 18.3× +13.73% (above 0%: growing) +46.15% (above 0%: growing) +57.89% (above 0%: growing) 32.59% 11.93% Compare
Median of peers $4.2B 26.8× 24.0× +9.59% +23.09% +13.63% 32.01% 9.60%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 8 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 9.27m 21.64m 203.71
2024 8.22m (1.87m) 148.34
2023 16.61m 22.23m 215.41
2022 6.75m 10.07m 192.39
2021 8.42m 13.14m 181.84

Ownership

Directors and executive officers, together 1.70%
BlackRock, Inc. 13.50%
The Vanguard Group, Inc. 12.50%
Wellington Management Group LLP 8.50%
FMR LLC 5.50%
Durable Capital Partners LP 5.20%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Option Care Health, Inc. (OPCH) Latest News

12 Oct

Impact 4 · · Simply Wall St.

9 Oct

Impact 5 · · Simply Wall St.
Impact 4 · · Insider Monkey
Impact 3 · · Simply Wall St.

7 Oct

Impact 4 · · TheStreet
Impact 4 · · Zacks

6 Oct

Impact 4 · · StockStory
Impact 4 · · Insider Monkey
Impact 4 · · The Motley Fool
Impact 4 · · MT Newswires
Impact 4 · · InvestorsHub
Impact 4 · · TIKR
Impact 4 · · Proactive Investors
Impact 4 · · Bloomberg
Impact 4 · · Business Wire
Impact 4 · · MT Newswires

5 Oct

Impact 4 · · Stocktwits
Impact 4 · · Investing.com

1 Oct

Impact 4 · · StockStory

30 Sep

Impact 4 · · Zacks
Impact 3 · · Simply Wall St.
Impact 3 · · Zacks

29 Sep

Impact 4 · · Zacks

22 Sep

Impact 3 · · StockStory

4 Sep

Impact 3 ·

7 Aug

Impact 3 · · The Motley Fool transcript

1 Aug

Impact 3 ·

30 Jul

Impact 3 ·

29 Jul

Impact 4 · transcript
Impact 4 · · Moby transcript

OPCH metrics, ten years each

stockrow.com/OPCH · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com